219 related articles for article (PubMed ID: 31537413)
1. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease.
Rhee JJ; Han J; Montez-Rath ME; Kim SH; Cullen MR; Stafford RS; Winkelmayer WC; Chertow GM
J Diabetes Complications; 2019 Nov; 33(11):107423. PubMed ID: 31537413
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic drug use trends in patients with type 2 diabetes mellitus and chronic kidney disease: A cross-sectional analysis of the National Health and Nutrition Examination Survey.
Gor D; Gerber BS; Walton SM; Lee TA; Nutescu EA; Touchette DR
J Diabetes; 2020 May; 12(5):385-395. PubMed ID: 31652390
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs.
Lamine F; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2016; 146():w14282. PubMed ID: 26922155
[TBL] [Abstract][Full Text] [Related]
4. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.
Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX
Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711
[TBL] [Abstract][Full Text] [Related]
5. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
[TBL] [Abstract][Full Text] [Related]
6. Impact of sex and glucose-lowering treatments on hypoglycaemic symptoms in people with type 2 diabetes and chronic kidney disease. The French Chronic Kidney Disease - Renal Epidemiology and Information Network (CKD-REIN) Study.
Balkau B; Metzger M; Andreelli F; Frimat L; Speyer E; Combe C; Laville M; Jacquelinet C; Briançon S; Ayav C; Massy Z; Pisoni RL; Stengel B; Fouque D
Diabetes Metab; 2019 Apr; 45(2):175-183. PubMed ID: 29706470
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States.
Koro CE; Lee BH; Bowlin SJ
Clin Ther; 2009 Nov; 31(11):2608-17. PubMed ID: 20110005
[TBL] [Abstract][Full Text] [Related]
8. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
[TBL] [Abstract][Full Text] [Related]
9. Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects.
Sloan LA
J Diabetes; 2019 Dec; 11(12):938-948. PubMed ID: 31318152
[TBL] [Abstract][Full Text] [Related]
10. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
[TBL] [Abstract][Full Text] [Related]
11. Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.
Ko SH; Kim DJ; Park JH; Park CY; Jung CH; Kwon HS; Park JY; Song KH; Han K; Lee KU; Ko KS;
Medicine (Baltimore); 2016 Jul; 95(27):e4018. PubMed ID: 27399082
[TBL] [Abstract][Full Text] [Related]
12. Treatment choices for the glycaemic management of patients with type 2 diabetes and chronic kidney disease: Analysis of the SAIL patient linked dataset.
Min T; Davies GI; Rice S; Chess J; Stephens JW
Diabetes Metab Syndr; 2018; 12(2):123-127. PubMed ID: 29239764
[TBL] [Abstract][Full Text] [Related]
13. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.
Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB
Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069
[TBL] [Abstract][Full Text] [Related]
14. Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
Dimnjaković J; Buble T; Ivanko P; Poljičanin T; Karanović Štambuk S; Brborović H; Brborović O
PLoS One; 2024; 19(3):e0301056. PubMed ID: 38536830
[TBL] [Abstract][Full Text] [Related]
15. Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?
Muller C; Dimitrov Y; Imhoff O; Richter S; Ott J; Krummel T; Bazin-Kara D; Chantrel F; Hannedouche T; ;
J Diabetes Complications; 2016; 30(4):675-80. PubMed ID: 26900098
[TBL] [Abstract][Full Text] [Related]
16. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
[No Abstract] [Full Text] [Related]
17. Management of type 2 diabetes in chronic kidney disease.
Triozzi JL; Parker Gregg L; Virani SS; Navaneethan SD
BMJ Open Diabetes Res Care; 2021 Jul; 9(1):. PubMed ID: 34312158
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease in type 2 diabetes patients in France: prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes.
Detournay B; Simon D; Guillausseau PJ; Joly D; Verges B; Attali C; Clement O; Briand Y; Delaitre O
Diabetes Metab; 2012 Apr; 38(2):102-12. PubMed ID: 22252014
[TBL] [Abstract][Full Text] [Related]
19. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.
Burgmann K; Fatio S; Jordi B; Rutishauser J
Swiss Med Wkly; 2013; 143():w13871. PubMed ID: 24163110
[TBL] [Abstract][Full Text] [Related]
20. Optimal medication dosing in patients with diabetes mellitus and chronic kidney disease.
MacCallum L
Can J Diabetes; 2014 Oct; 38(5):334-43. PubMed ID: 25284697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
